Case review is inconsistent, wasting time and money while frustrating patients.

In this traditional model, patients may continue using a therapy providing no real benefit, costing payors millions in mounting drug and claims costs.



Case review is consistent and results are dependable and communicated clearly.

With InCircle Review, only patients needing therapy are approved, ensuring they receive the right drug at the right dose without significantly adding to the initial treatment timeline.



Our proprietary algorithm is backed
by disease state experts on staff.

Our proprietary algorithm is backed by disease state experts on staff.

At InCircle Review, we’ve reinvented how specialty drug cases are reviewed and approved from the ground up. We review every case so you don’t have to.

Submit Your Records

Securely submit all examination, test results, and other documentation into the InCircle Review Portal (which can be added to a payor website).

Data is Reviewed

Our proprietary algorithm and disease state experts
verify case data against payor policies and a final
recommendation is created based on the analysis.

Our proprietary algorithm and disease state experts verify case data against payor policies and a final recommendation is created based on the analysis.

Data is Reviewed
Results are Shared

Results are Shared

The data leading to the recommendation, along with a summary of findings, is made available, with key stakeholders and care providers alerted as necessary.

You Save Money and
Improve Outcomes

You Save Money and Improve Outcomes

The InCircle Review model helps you save on your drug spend while improving patient outcomes without unnecessary therapy, time, or costs.

Why InCircle Review?

Eliminate Guesswork. Minimize Waste. Lower Costs.

More than 50% of patients are prescribed drugs inappropriately.

InCircle Review was created to improve utilization, minimize misdiagnosis, and enhance clinical outcomes for patients with complex neurological disorders.

Every case we review with our proprietary algorithm-based approach ensures transparent and consistent communication so all stakeholders know exactly why a treatment is being rejected or utilized.

Created by leading neuromuscular physicians Jonathan Katz, M.D., and Todd Levine, M.D., InCircle Review helps payors and MCOs improve care, minimize waste, and decrease drug spend for expensive therapies like Intravenous Immunoglobulin Therapy (IVIg).

Schedule Demo


Let’s Connect

Let’s Connect

Let’s Chat

Discover if InCircle Review can help reduce your drug spend and improve patient outcomes. Schedule a demo today.


Frequently Asked Questions and Answers

Yes, InCircle Review encompasses multiple disease states including neuropathies, myopathies, myasthenia gravis, immune deficiencies, and many other immune-mediated conditions. The process for each disease state is the same and requires no additional work on you or your team.
Patient information is submitted to our HIPAA compliant secure portal by the prescriber via electronic submission. Once we have the data, we will review it and reach out with our findings as soon as possible.
Should additional information be required following your initial submission, the provider will be notified as soon as possible. If information is complete and we have everything we need, the provider is notified the information has been submitted to the insurance plan for final review. Regardless, providers are kept in the loop with up-to-date information every step of the InCircle Review process.
Review results are available via the secure portal on a patient-specific basis. Results will include potential differential diagnoses, as well as treatment suggestions.
Submitted cases are typically reviewed within 24-48 hours, but guidelines for turnaround time can be structured to meet provider needs and insurance plan requirements.
There are multiple options available to securely transmit results to the appropriate stakeholder, but the most common include portal look-up and secure e-mail. If you need the data transmitted in a different format, let us know and we will do our best to accommodate your requirements.

Historically, annual savings of 40% has been identified in the Ig cases reviewed. Click here to see the Insights White Paper with examples of potential savings.

Can InCircle Review Work for You?

Take this 2-minute assessment to determine if InCircle Review can work for you.

Find Out